Showing results (1201-1210 of 1,911) with videos related to
Sort By:
Pageof 192
Current Neuropharmacology|December 8, 2015
mGlu5, Dopamine D2 and Adenosine A2A Receptors in L-DOPA-induced DyskinesiasNicolas Morin, Marc Morissette, Laurent Grégoire, et al.Current Neuropharmacology|December 9, 2015
Drug Therapy for Behavioral and Psychological Symptoms of DementiaFeng Wang, Ting-Yi Feng, Shilin Yang, et al.Current Neuropharmacology|November 21, 2015
Current Pharmaceutical Treatments and Alternative Therapies of Parkinson's DiseaseJie Dong, Yanhua Cui, Song Li, et al.Current Neuropharmacology|October 31, 2015
LRRK2 Kinase Inhibition as a Therapeutic Strategy for Parkinson's Disease, Where Do We Stand?Jean-Marc Taymans, Elisa GreggioCurrent Neuropharmacology|May 10, 2016
Tumour-Derived Glutamate: Linking Aberrant Cancer Cell Metabolism to Peripheral Sensory Pain PathwaysJennifer Fazzari, Katja Linher-Melville, Gurmit SinghCurrent Neuropharmacology|November 27, 2014
Combination of therapeutic hypothermia and other neuroprotective strategies after an ischemic cerebral insultJoline Goossens, Saïd Hachimi-IdrissiCurrent Neuropharmacology|November 27, 2014
The Gastrin-Releasing Peptide Receptor (GRPR) in the Spinal Cord as a Novel Pharmacological TargetKeiko Takanami, Hirotaka SakamotoCurrent Neuropharmacology|November 27, 2014
The role of ketamine in treatment-resistant depression: a systematic reviewGianluca Serafini, Robert H Howland, Fabiana Rovedi, et al.Current Neuropharmacology|June 10, 2016
Molecular Hydrogen as a Neuroprotective AgentMasumi Iketani, Ikuroh OhsawaCurrent Neuropharmacology|June 15, 2016
Group I mGluR Induced LTD of NMDAR-synaptic Transmission at the Schaffer Collateral but not Temperoammonic Input to CA1Stephen Fitzjohn, Zafar Bashir, Paul FarrowPageof 192